Our Vision

XTransplant will abolish the organ shortage crisis by providing immediate access to transplantable hearts for patients in terminal disease.

Our Vision

XTransplant will abolish the organ shortage crisis by providing immediate access to transplantable hearts for patients in terminal disease.

Our Vision

The Developmental Roadmap of XTransplant foresees the start of a clinical pilot trial in 2024

2018
- Landmark publication setting the path to launch XTransplant:
  Laengin et al: Consistent success in life-supporting porcine cardiac xenotransplantation. Nature 2018; 564:430-433
2019
- Winner of the Medical Valley Award 2019 (Euro 250K)
- Scientific Advice by the Paul Ehrlich Institute/European Medicines Agency to set up a path for clinical trials
- Patent Application
2020 - 2023
- Launch of XTransplant GmbH in Munich December 2020
- Development and engineering of safe, durable and humanized XTransplant organs
2022 - 2024
- Optimization and pre-clinical testing of safe, durable and humanized XTransplant organs
2024 - 2025
- Clinical pilot study of safe, durable and humanized XTransplant organs
2025 - 2027
- Start of regular clinical application of XTransplant organs

- Landmark publication setting the path to launch XTransplant:
  Laengin et al: Consistent success in life-supporting porcine cardiac xenotransplantation. Nature 2018; 564:430-433
- Winner of the Medical Valley Award 2019 (Euro 250K)
- Scientific Advice by the Paul Ehrlich Institute/European Medicines Agency to set up a path for clinical trials
- Patent Application
- Launch of XTransplant GmbH in Munich December 2020
- Development and engineering of safe, durable and humanized XTransplant organs
- Optimization and pre-clinical testing of safe, durable and humanized XTransplant organs
- Clinical pilot study of safe, durable and humanized XTransplant organs
- Start of regular clinical application of XTransplant organs